Anglesio et al. in 2017 characterized deep infiltrating endometriosis lesions from 39 patients and found that 26% harbored somatic cancer driver mutations, including alterations of KRAS, PIK3CA, ARID1A and PPP2R1A genes. This evidence concerns the gene PPP2R1A and cancer.